Rockwell Medical, Inc. (RMTI): EBITDA
-$2.50M
Year ended 2025-12-31
-$2.43M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$2.50M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $2.79M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$5.23M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$16.20M | n/m | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | -$29.67M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$27.59M | n/m | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | -$33.74M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$31.79M | n/m | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | -$25.41M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$19.45M | n/m | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | -$14.28M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$16.56M | n/m | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | -$46.05M | n/m | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | -$53.17M | n/m | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | -$20.51M | n/m | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | -$1.48M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$4.25M | n/a | 2012-03-05, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$2.50M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$362.94M | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $6.31M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$11.99M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$240.64M | n/m |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | -$80.76M | n/m |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | -$211.32M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $3.20M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$73.23M | n/m |
Compare RMTI, VRDN, SPRO, ASMB side by side · Screen every company in Pharmaceutical Preparations ↗